Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00114413 · ClinicalTrials.gov registry record · NA

Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents

A NA study of Asthma, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
NA
Development phase
547
Enrollment target
12
Study locations

NCT00114413 is a NA study of Asthma that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 547 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (65% lower). The trial reports 12 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00114413, a NA study of Asthma, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
NA
Development phase
547 participants
Enrollment target
12
Study locations

Study Summary

The purpose of ICAC-01 is to determine whether an asthma treatment strategy that measures exhaled nitric oxide (eNO) to indicate disease progression is more effective in treating asthma symptoms when combined with existing asthma treatment guidelines than treatment using the guidelines alone.

Conditions Studied

Asthma

Interventions

  • DRUG Inhaled corticosteroids
  • PROCEDURE eNO measurement

Study Locations (12)

Arizona

  • University of Arizona (DAIT-ICAC-01/02) - Tucson

Colorado

  • National Jewish Medical and Research Center (DAIT-ICAC-01/02) - Denver

District of Columbia

  • Howard University - Washington D.C.

Illinois

  • Children's Memorial Hospital - Chicago

Maryland

  • Johns Hopkins University - Baltimore

Massachusetts

  • Boston University School of Medicine - Boston

Missouri

  • Washington University School of Medicine - St Louis

New York

  • Mount Sinai (DAIT-ICAC-01/02) - New York

Trial Details

FieldValue
Enrollment Target 547 participants
Start Date 2004-08
Est. Completion 2006-11
Phase NA

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

2,006 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00114413

The ClinicalTrials.gov registry entry for NCT00114413 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 547 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (65% lower). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Inhaled corticosteroids is the first listed.

NCT00114413 reports 12 study locations spanning 12 distinct geographic areas - top geographies include Arizona, Colorado, District of Columbia.

Frequently Asked Questions

What is clinical trial NCT00114413 about?

NCT00114413 is a clinical study titled "Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents". The purpose of ICAC-01 is to determine whether an asthma treatment strategy that measures exhaled nitric oxide (eNO) to indicate disease progression is more effective in treating asthma symptoms when combined with existing asthma treatment guidelines than treatment using the guidelines alone.

What is the current status of trial NCT00114413?

This trial is currently completed. It is a NA study. The enrollment target is 547 participants. The study started on 2004-08. Estimated completion is 2006-11.

What conditions does trial NCT00114413 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT00114413?

The interventions under investigation include: Inhaled corticosteroids (DRUG), eNO measurement (PROCEDURE).

Who is sponsoring clinical trial NCT00114413?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00114413 being conducted?

This trial has 12 study locations across Arizona, Colorado, District of Columbia, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.